SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
New Publication in Science Shows That Agios Pharmaceuticals' IDH1 Inhibitor Can Reverse Cancer-Causing Effects of Oncometabolite 2-HG in Leukemia Model